Best HLTH Podcasts (2025)

1
Decoding Cancer : Dr. Edgar Engleman, Professor of Pathology, Stanford University 1:16:42

Play Pause

1d ago1:16:42

1:16:42

In this episode, I sit down with Dr. Edgar Engleman, a pioneering Pathologist and physician-scientist at Stanford University whose work has shaped the very foundation of cancer immunotherapy. As we face rising global cancer rates, Dr. Engleman shares his insights into the evolving landscape of cancer research and what the numbers really mean—scient…

1
Unicorns, AI, and the future of health: Highlights from HLTH Europe 2025 1:04:16

8d ago1:04:16

1:04:16

The second annual HLTH Europe conference brought together health leaders, start-ups, investors, and developers from across the globe for a mid-year pulse check on where healthcare innovation stands today – and where it’s headed next. Amid economic uncertainty and shifting regulatory priorities, pharma, health tech, and care delivery are all racing …

1
Special: HLTH Europe Recap 32:58

19d ago32:58

32:58

In this special episode of Unstable Vitals, your hosts Dr. Adam Brown and Dr. Lara Zibners dive into their experience at the HLTH Europe conference in Amsterdam — a dynamic, innovation-driven gathering for health tech startups, investors, and industry leaders. They share what made the event stand out, from the high-energy networking and startup pit…

1
2025 HLTH Europe roundup 42:34

24d ago42:34

42:34

SomX’s Jessica Somauroo is joined by Dr Derrick Khor and Blanca Baez at HLTH Europe for the latest news and developments from across the healthtech ecosystem. 🗞 Grab the newsletter at www.healthtechpigeon.com ✍️ Apply to be a podcast guest using this form 🖇 Connect with Jessica on LinkedIn 🖇 Connect with Derrick on LinkedIn 🖇 Connect with Blanca on…

1
Ben Sidders on integrating causality in AI for R&D success 15:26

17h ago15:26

15:26

For AI to truly revolutionise drug discovery, it must move beyond pattern recognition and predictive analytics to include causality, which is essential for technical and regulatory success in drug discovery. In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Ben Sidders, chief scientific officer at Biorelate, a company leveraging …

1
Fighter Jets, Frontlines & First-Gen Dreams: A STEM Life with Dr. Owais Durrani 46:51

23h ago46:51

46:51

In this episode of Unstable Vitals, ER docs-turned-entrepreneurs Dr. Adam Brown and Dr. Lara Zibners sit down with Dr. Owais Durrani — emergency physician, media personality, STEM advocate, and Coldplay superfan — for an unfiltered conversation that flies from fighter jets to frontline care. A first-generation college student, Dr. Durrani shares ho…

1
259: Our expensive new normal: why traditional drug cost controls are obsolete 32:19

1d ago32:19

32:19

Treatments like cell and gene therapies (CGTs) and GLP-1s are transforming care, but with double-digit growth in drug spend year over year, this transformation comes with an unsustainable price tag. And it’s putting pressure on every part of the healthcare ecosystem, from patients and providers to employers and health plans. The strategies that pur…

1
How can we see real scale in the NHS? 52:23

3d ago52:23

52:23

SomX’s Belle Taylor and Huw Penson dive into this week's healthtech news with PocDoc's Steve Roest 00:00 - Intro 02:25 - Tech-led NHS could boost UK economy by £40bn 29:00 - Samsung to buy US health tech firm Xealth in digital health push 42:50 - Comprehensive policies for scaling systemic and equitable integration of digital health technologies 🗞 …

1
On nuclear medicine and oncology, SHINE technologies 25:32

6d ago25:32

25:32

Radiopharmaceutical therapy has attracted increasing attention in the treatment of refractory diseases that are not sensitive to current therapies, such as in oncology. In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Greg Piefer, founder and CEO of SHINE Technologies, a nuclear fusion company mastering more immediate applicatio…

1
258: The ‘One Big, Beautiful Bill Act’: What’s changing, who’s affected, and what to do now 6:12

8d ago6:12

6:12

On July 4th, 2025, President Donald Trump signed the “One Big Beautiful Bill Act” into law. In this “minisode,” host Rachel (Rae) Woods unpacks the sweeping implications of the most significant healthcare legislation since the Affordable Care Act. From enhanced subsidies expiring to major cuts to Medicaid and ACA marketplace coverage on the horizon…

1
Is the NHS 10-Year plan worth reading? 1:00:29

10d ago1:00:29

1:00:29

SomX’s Jessica Somauroo and Huw Penson dive into the NHS 10 Year Plan with Malte Gerhold and Liam Cahill. 00:00 - Intro 04:00 - 10 Year Health Plan for England: fit for the future 🗞 Grab the newsletter at www.healthtechpigeon.com ✍️ Apply to be a podcast guest using this form 🖇 Connect with Jessica on LinkedIn 🖇 Connect with Huw on LinkedIn 🖇 Conne…

1
On patient-centric treatment decisions and the value of quantitative methodologies, in conversation with Marc Buyse 16:33

13d ago16:33

16:33

In today's healthcare landscape, there is a pressing need for quantitative methodologies that include the patients' perspective in any treatment decision. In a new pharmaphorum podcast, web editor Nicole Raleigh spoke with Marc Buyse, founder of IDDI and One2Treat, and also co-founder of CluePoints, about his recent work as one of the editors of – …

1
Maximising value by uniting the digital backbone: On a new Novo Nordisk and Veeva partnership 13:40

15d ago13:40

13:40

At this year’s Veeva R&D and Quality Summit, it was revealed that Novo Nordisk and Veeva have entered into a new partnership for clinical development. In this episode of the pharmaphorum podcast, web editor Nicole Raleigh spoke with Stephanie Bova, chief digital officer at Novo Nordisk, and Rik van Mol, SVP R&D and Quality at Veeva, about the partn…

1
257: Paul Markovich on new builds, breakups, and bold healthcare bets 46:12

15d ago46:12

46:12

In this special live episode from the 2025 Advisory Board Summit, host Rachel (Rae) Woods sits down with a leader well-versed in bold transformation: Paul Markovich. After more than a decade as President and CEO of Blue Shield of California, Paul now leads Ascendiun—a new nonprofit parent company that includes Blue Shield of California, its clinica…

1
Paging Dr. Burnout: When the White Coat Comes Off 37:45

15d ago37:45

37:45

In this episode of Unstable Vitals, hosts Dr. Adam Brown and Dr. Lara Zibners sit down with Dr. Melissa Parsons, a former top pediatrician turned life coach, to unpack the emotional cost of surviving in the healthcare system. Melissa shares her deeply personal journey from burnout and perfectionism to finding healing through coaching, vulnerability…

1
How is AI helping to speed up diagnosis? 39:09

17d ago39:09

39:09

SomX’s Belle Taylor, Andrew Hair and Leed's Teaching Hospitals NHS Trust Dr Fahmid Chowdhury dive into the weeks’ healthtech stories. 00:43 - New AI chest X-ray software to speed up diagnosis and improve patient care 21:35 -NHS plans to DNA test all babies to assess disease risk 🗞 Grab the newsletter at www.healthtechpigeon.com ✍️ Apply to be a pod…

1
HealthierU | Barred from Care: The Prison Medical Crisis 12:44

21d ago12:44

12:44

In this episode, we delve into how inadequate medical care in correctional facilities exacerbates mental and physical health issues and creates lasting burdens on those inside and outside of the system. How can we call a system “just” when it fails to prioritize health and rehabilitation, forcing incarcerated individuals into a daily struggle for s…

1
The changing landscape of drug clinical assessment: Tommy Bramley on the JCA 18:11

22d ago18:11

18:11

The JCA process was passed into law by the European Union in 2022. The Joint Clinical Assessment is a process that will systematically assess all available clinical evidence for new drugs. Rolled out in stages, starting with oncology drugs and advanced therapy medicinal products this year, it will be fully implemented by 2030. In a new pharmaphorum…

1
256: How you can prepare for the financial impacts of Trump-era policies 31:07

22d ago31:07

31:07

Healthcare executives are closely watching legislative activity in Congress—anticipating shifts in government-funded insurance, new economic headwinds, and regulatory changes. And while change is certainly coming, what remains uncertain is how these forces will shape market dynamics and organizational finances. To help hospitals and health systems …

1
Precision, speed, impact: Evolving mass spectrometry for medical science 19:22

27d ago19:22

19:22

Originally employed in atomic physics, mass spectrometry is now an indispensable tool in modern science, and importantly medical science. In a new pharmaphorum podcast, web editor Nicole Raleigh spoke with Melissa Sherman, CEO of MOBILion Systems, a company pioneering next-generation separation science, by innovating best-in-class instruments that …

1
HealthierU | Being a Student Sucks, But Why? 8:34

28d ago8:34

8:34

In this episode, host Tre’ Harp tackles the issue of student mental health after reading a viral article that supposedly ranked the most depressed universities, with Emory coming in at No. 4. To get to the bottom of the question of what is going on with the depression on campus, Tre’ talks with fellow students including Nasneen Abdalim about what i…

1
IMUNON at ASCO 2025: Changing the micro-tumour environment in advanced ovarian cancer 14:14

29d ago14:14

14:14

Onsite at ASCO 2025 in Chicago, web editor Nicole Raleigh sat down with Dr Stacy Lindborg, CEO of IMUNON, to discuss the company’s oral presentation at the Congress from the Phase 2 OVATION 2 study of IMNN-001, an IL-12 immunotherapy, in women with newly diagnosed advanced ovarian cancer – since published in the peer-reviewed journal Gynecologic On…

1
255: Is healthcare really recession-proof? 39:50

29d ago39:50

39:50

When experts warn that the economy could be headed for a recession, people working across different corners of the economy get nervous. People working in healthcare, maybe less so. That’s because of a longstanding idea that healthcare is impervious to recession. Okay, maybe that’s overstating it. Healthcare is less susceptible than other industries…

1
What's the Big Deal? 49:10

29d ago49:10

49:10

Episode 2 of Unstable Vitals features hosts Dr. Lara Zibners and Dr. Adam Brown, as they offer an unfiltered and often humorous look into the realities of emergency medicine. They delve into why people are so fascinated by ER stories, particularly the more bizarre and gruesome ones, a common question they face at social gatherings. The hosts share …

1
Hacking Human Recovery: The Former Lawyer Who's Revolutionizing How We Sleep 48:56

29d ago48:56

48:56

In this compelling episode, I sit down with Matteo Franceschetti, the Italian-born Co-Founder and CEO of Eight Sleep, to explore how his journey from competitive ski racing to legal practice to clean-tech entrepreneurship led him to revolutionize the $500 million sleep optimization industry. Franceschetti shares his unique perspective on performanc…

1
How can women protect their health data? 45:04

1M ago45:04

45:04

SomX’s Jessica Somauroo and Amy Thomas dive into the weeks’ healthtech stories. 00:00 - Intro 17:28 - Public health bodies urged to launch period tracking apps to protect data 🗞 Grab the newsletter at www.healthtechpigeon.com ✍️ Apply to be a podcast guest using this form 🖇 Connect with Jessica on LinkedIn 🖇 Connect with Amy on LinkedIn 📖 Learn mor…

1
Treating primary bone cancer: The potential of listeria-based bioengineered bacterial immunotherapy 18:37

1M ago18:37

18:37

Osteosarcoma is an extremely challenging and often aggressive cancer that has particular treatment challenges due to location, changing genotypes, and high recurrence rates. It mostly affects children and young adults under 20 years of age. In a new pharmaphorum podcast, web editor Nicole Raleigh spoke with Paul Romness, president and CEO of OS The…

1
HealthierU | How Can We Find Meaning in College? 11:30

1M ago11:30

11:30

How do college students find purpose amidst the hustle and bustle of academic deadlines, internships, and social pressures? In this episode of HealthierU, host Abby Weisenfeld dives into the challenges and joys of discovering meaning in everyday life by drawing on published research and talking with Dr. Christine Whelan, Emory University's “Purpose…

1
254: Stop searching for the “perfect” AI product and do this instead 29:31

1M ago29:31

29:31

Artificial intelligence (AI) continues to generate excitement across healthcare, promising to reduce clinician burnout, fuel innovation, and ease financial pressures. But despite the hype, AI is far from a “plug-and-play” solution—and simply investing in AI won’t guarantee success. This week, host Rachel (Rae) Woods is joined by Advisory Board AI e…

1
How is Neurotech changing the industry 26:35

1M ago26:35

26:35

SomX’s Huw Penson, Andrew Hair and Hollie Ruda dive into the weeks’ healthtech stories. 00:00 - Intro 01:25 - Musk's Neuralink raises $650 million in latest funding as clinical trials begin + A Neuralink Rival Just Tested a Brain Implant in a Person 12:10 - atai Life Sciences and Beckley Psytech to Combine Creating a Global Leader in Psychedelic Me…

1
Servier’s ASCO 2025 Data: Advancing IDH-Mutated Cancer Treatment with Tibsovo & Voranigo 9:25

1M ago9:25

9:25

At ASCO 2025, Servier presented data in the IDH-mutated cancer space. Onsite at McCormick Place in Chicago, pharmaphorum web editor Nicole Raleigh spoke with Becky Martin, chief US medical at Servier about the key data from the company’s Tibsovo and Voranigo programmes, as well as the implications for patients and the wider themes of the Congress t…

1
Where innovation meets collaboration: Live from Manchester’s City labs 4.0 38:15

1M ago38:15

38:15

In healthcare, some of the most meaningful innovations happen when the right people are brought together in the right place. True progress depends on systems and infrastructure designed to connect ideas, people, and expertise across sectors. Citylabs 4.0, now open in the heart of Manchester’s Knowledge Quarter on the Oxford Road Corridor, was built…

1
Live from ASCO 2025: Boehringer Ingelheim on unmet needs and oncology innovation 9:57

1M ago9:57

9:57

Boehringer Ingelheim’s data presented at ASCO 2025 reflected the company’s broad pipeline and growing body of evidence supporting innovative therapies for various cancers. In a pharmaphorum podcast recorded onsite at the Congress, web editor Nicole Raleigh spoke with Itziar Canamasas, global head of oncology at Boehringer Ingelheim, for a discussio…

1
HealthierU | What is POTS, and why are so many female athletes getting it? 8:52

1M ago8:52

8:52

More and more, otherwise healthy female athletes are getting diagnosed with something called Postural Orthostatic Tachycardia Syndrome (POTS, for short). Often, the first signs of POTS are feeling faint when standing up, or noticing a rapid heartbeat. POTS is a condition that affects blood flow and can cause symptoms like dizziness, rapid heart rat…

1
253: A new way to measure patient access 29:05

1M ago29:05

29:05

Stay tuned to the end of the episode for a policy update on the bill containing Medicaid cuts that is making its way through Congress, and the recent MAHA Commission Report. If you were to ask any healthcare leader what the top challenges in our industry are, it’s a fair bet that “improving patient access to care” would be on the list. There have b…

1
The Neuroeconomics Edge: Decision Science for Better Health with Dr. Michael Platt 2:05:23

1M ago2:05:23

2:05:23

I’ve always been fascinated by the mystery behind our choices — why we hit snooze instead of going for a walk, why we reach for comfort food even when we know better, and why some people seem to have the willpower to make healthier decisions with ease. This week on HLTH Forward, I had the absolute privilege of diving deep into those questions with …

1
Is the UK is becoming a leader in healthtech? 33:21

2M ago33:21

33:21

SomX’s Huw Penson, Amy Thomas and Hollie Ruda dive into the weeks’ healthtech stories. [00:00] - Intro [01:34] - Amazon-style’ prescription tracking goes live on NHS App [13:14] - Hinge Health goes public, raises $437.3M in IPO [21:45] - UK health tech startups worth £32bn, report finds 🗞 Grab the newsletter at www.healthtechpigeon.com ✍️ Apply to …

1
Bringing patients to research centres: Using AI to bring efficiencies forward 19:07

2M ago19:07

19:07

Trends can be predicted, and trends can unfold. Here, Liz Beatty – co-founder and chief strategy of Inato – speaks to the beginnings of a new era in drug development brought on by key technological advances in AI. Historically, large urban academic centres have conducted the majority of clinical trials, leading to such issues as inaccessibility, la…

1
HealthierU | Inside Med Student Burnout: Who Heals the Healer? 13:01

2M ago13:01

13:01

Burnout, depression, and even suicide rates among physicians have reached alarming levels, raising the critical question: Who heals the healers? In this episode of HealthierU, we dive into the mental health challenges faced by healthcare professionals, starting with pre-med students and continuing through residency and beyond. One-time Emory pre-me…

1
252: Contain, extract, recover: Inside the Ardent Health cyberattack 41:08

2M ago41:08

41:08

In this special live episode from the 2025 Advisory Board Summit, Ardent Health Services President & CEO Marty Bonick and Chief Digital and Transformation Officer Anika Gardenhire recount the harrowing story of a ransomware attack that brought their 30-hospital system to a standstill on Thanksgiving Day 2023. Cyberattacks on healthcare systems are …

1
How to effectively tackle digital exclusion in healthcare 44:08

2M ago44:08

44:08

SomX’s Belle Taylor and Amy Thomas dive into the weeks’ healthtech stories with the help of The Health Foundations’ Tom Hardie. 00:00 - Intro 00:40 - Digitizing the NHS and adult social care 16:10 - Can AI therapists really be an alternative to human help? 30:40 - Digital Inclusion Under the Microscope as Digital Poverty Alliance launches NHS Secto…

1
The need for a science-first mindset: The vaccine landscape today 19:34

2M ago19:34

19:34

As has been widely reported on, immunisation rates, including for flu and RSV, have been falling – at a troubling rate – and diseases like whooping cough and measles have seen a worrying resurgence due to anti-vaxxers. And not just in the US. In a new pharmaphorum podcast, Rebecca Catterick, General Manager for Vaccines, UK & Ireland, at Sanofi, di…

1
HealthierU | Can bad posture affect your mood? 9:41

2M ago9:41

9:41

This episode delves into the growing epidemic of "tech neck,” a modern issue arising from our sedentary lifestyles and excessive screen use. We all know neck pain can be uncomfortable, but did you know it can also increase stress, impact your mood, and lead to a sense of overwhelm? We talk with Emory students who’ve experienced neck discomfort, as …

1
251: Former HHS leaders weigh in on navigating Trump 2.0 (and answer your questions) 40:25

2M ago40:25

40:25

5/22 Update: The House early Thursday narrowly passed the One Big Beautiful Bill Act, a budget bill that includes a number of healthcare provisions that could have a significant impact on Medicaid, Medicare, and the Affordable Care Act. It has been over 100 days since President Donald Trump began his second term. During that time, Radio Advisory ha…

1
EAPs: Market access outside of the US and Western Europe 13:36

2M ago13:36

13:36

Early access programmes (EAPs) for novel medicines are an often-misunderstood strategy outside of western markets. In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Cem Zorlular, CEO of Er-Kim Pharmaceuticals, a company that has been serving as a regional affiliate for pharma and biotech since 1981 in the CEE and Mediterranean. M…

1
The Four-Day Formula : Dale's Vision for Modern Work Culture For Better Health, Dr. Dale Whelehan, Founder @ Four Day Work Week 1:06:23

2M ago1:06:23

1:06:23

In this episode I had the opportunity to interview a fascinating behavioral scientist and former CEO of Four Day Week Global about the concept of reduced working hours- Dr. Dale Whelehan. He explained how his interest in this field began when observing surgeons suffering from impaired decision-making and emotional regulation due to excessive workin…

1
One month Countdown to HLTH Europe: Everything you need to know 43:43

2M ago43:43

43:43

Huw and Amy from SomX breaks down the best stories from this week’s newsletter with help from HLTH's Henry Stoneley. 06:18 - The new Finland: How Portugal has become a hub for health tech innovation 17:00 - Mark Zuckerberg wants you to have more friends … but AI 28:10 - Only 30% of Health and Social providers Using AI, New Survey Reveals 🗞 Grab the…

1
HealthierU | What Are Food Allergies, Really? 9:22

2M ago9:22

9:22

Sisters Yulan and Joleigh Yim used to love eating Korean food — until they were both diagnosed with food allergies as adults. In this episode, we explore the science behind food allergies with Dr. Dan Benardot, a registered dietitian and Fellow of the American College of Sports Medicine, who explains the difference between an allergy, an intoleranc…

1
250: VBC success is possible. Here's how Advocate Health does it. 34:16

2M ago34:16

34:16

Believe it or not, 60% of healthcare payments in the US are tied to value. But it’s still surprisingly hard to find examples of health systems that have been doing VBC at scale, successfully, over time. So that’s what Advisory Board researchers set out to do. And across 66 conversations with 44 systems, we found four systems with approaches worth e…

1
All things digital twins 52:40

2M ago52:40

52:40

James SomX breaks down the best stories from this week’s newsletter with help from Sanome's, Benedikt von Thüngen, 01:31 - Belfast Digital Twin Centre to fast track industrial adoption of deep tech 🗞 Grab the newsletter at www.healthtechpigeon.com ✍️ Apply to be a podcast guest using this form 🖇 Connect with James on LinkedIn 🖇 Connect with Benedik…